HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH RSS TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Malhi, H. Articles by Gupta, S. Search for Related Content PubMed PubMed Citation Articles by Malhi, H. Articles by Gupta, S.

^99mTc-Mebrofenin Scintigraphy for Evaluating Liver Disease in a Rat Model of Wilson’s Disease

¹ Marion Bessin Liver Research Center, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York
² Division of Nuclear Medicine, Long Island Jewish Medical Center, New Hyde Park, New York
³ The National Center for the Study of Wilson’s Disease, St. Luke’s–Roosevelt Hospital Center, New York, New York
⁴ Division of Hepatology and Transplant Institute, Mount Sinai School of Medicine, New York, New York

The purpose of this study was to establish whether ^99mTc-mebrofenin could noninvasively assess liver function in Wilson’s disease. Methods: Long–Evans Cinnamon (LEC) rats, which reproduce Wilson’s disease with copper toxicosis, and their normal counterparts, Long–Evans Agouti (LEA) rats, were studied. Scintigraphic findings were correlated with biliary mebrofenin excretion and residual organ counts and with hepatic copper content, histology, copper excretion capacity, and liver test results. Results: Serum alanine aminotransferase (ALT) levels were elevated in some LEC rats, whereas serum bilirubin levels were normal. Liver histology was normal in LEA rats, whereas LEC rats showed multiple abnormalities. Mebrofenin was incorporated rapidly in LEA rats, with a mean time to peak liver activity of 80 ± 30 s, followed by prompt biliary excretion of the tracer. In LEC rats, the mean time to peak activity, 283 ± 190 s, was significantly longer (P = 0.001). The time to half of peak activity, indicating tracer clearance, was significantly greater in LEC rats than in LEA rats (1,825 ± 1,642 s vs. 524 ± 82 s, P = 0.002). Hepatic mebrofenin handling correlated with hepatic copper content, histologic grade, copper excretion capacity, and serum ALT. Conclusion: Correlation of ^99mTc-mebrofenin handling with liver morphology, function, and copper accumulation in LEC rats suggests that mebrofenin scintigraphy can be useful for noninvasively monitoring disease progression and therapeutic response in Wilson’s disease. Although the data were obtained in an animal model of Wilson’ disease, these biochemical parameters likely reflect liver damage in general, suggesting that there may be a role for mebrofenin scintigraphy in other chronic liver diseases as well.

Key Words: ^99mTc-mebrofenin • Wilson’s disease • liver

This article has been cited by other articles:

				W. de Graaf, R. L. Vetelainen, K. de Bruin, A. K. van Vliet, T. M. van Gulik, and R. J. Bennink 99mTc-GSA Scintigraphy with SPECT for Assessment of Hepatic Function and Functional Volume During Liver Regeneration in a Rat Model of Partial Hepatectomy J. Nucl. Med., January 1, 2008; 49(1): 122 - 128. [Abstract] [Full Text] [PDF]

				B. Joseph, K. K. Bhargava, G. G. Tronco, V. Kumaran, C. J. Palestro, and S. Gupta Regulation of Hepatobiliary Transport Activity and Noninvasive Identification of Cytokine-Dependent Liver Inflammation J. Nucl. Med., January 1, 2005; 46(1): 146 - 152. [Abstract] [Full Text] [PDF]